REGIST LOGIN

로그인 회원가입

> 연구소 > 논문 / 학술활동

연구소 마마파파&베이비의 핵심인 베이비 드림 난임 연구소는
그간의 연구학술 성과에 안주하지 않고,
늘 한계를 뛰어넘기 위해 노력합니다.

반복 유산 여성에서 미세수정을 통한 시험관 시술은 자연 유산을 감소시키지 않는다.

2014년 유럽불임학회(ESHRE) P-045 ICSI did not reduce spontaneous abortion of women with recurrent miscarriage. (반복 유산 여성에서 미세수정을 통한 시험관 시술은 자연 유산을 감소시키지 않는다.)

Y.Y. Kim1, K.H. Lee1, I.H. Park1, H.G. Sun1, S.G. Kim1, J.H. Lee1, S.A. Kim1, S.J. Kwak1.
1 Mamapapa&baby Obstetrics Gynecology Clinic, Infertility Lab., Ulsan city, Korea South

Study question

Can ICSI be helpful in resolving paternal chromosomal abnormality in women with recurrent miscarriage and yielding a better clinical outcome?

Summary answer

In women with recurrent miscarriage with normal sperm, administration of ICSI for reducing paternal chromosomal abnormality did not have positive effect in the pregnancy and abortion rate.

What is known already

RM (recurrent miscarriage) is characterized by a heterogeneous population, and in more than 50% of the couples with RM, the cause of miscarriage remains unexplained. One of the RM risk factor is embryonal chromosomal abnormality. Due to the fact that ICSI can select sperm that shows a normal morphology, we supposed that it might possibly reduce paternal chromosomal abnormality. In our study, we aimed to determine whether ICSI can help women with recurrent miscarriage.

Study design, size, duration

All fresh, non-donor in vitro fertilization (IVF) cycles performed from January 2010 through December 2013 (n=223) were included in this study. A total of 141 patients underwent conventional IVF while 82 patients underwent IVF with ICSI.

Participants/materials, setting, methods

All patients had two or more spontaneous abortions, male factors were considered normal based on WHO standards. Outcome measures included method of fertilization, pregnancy rate, ongoing pregnancy rate and abortion rate.

Main results and the role of chance

Patient characteristics were similar in the two groups. In each group, age (IVF: 35.3±4.5; IVF with ICSI: 35.7±4.3 P=0.06), basal FSH (6.9±3.0; 6.2±3.2 mIU/ml P=0.18), duration of rFSH (10.0±2.2; 9.3±2.0 P=0.18), and endometrial thickness (10.3±1.3; 9.9±2.0 P=0.58) did not show significant differences. There were no significant differences between two groups in the number of MII oocytes (11.8±8.0; 10.6±7.3 P=0.51), fertilization rate (92.3±13.3; 88.6±16.5 p=0.07), pregnancy rate (47.5%; 47.6% P=0.93), ongoing pregnancy rate (41.8%; 41.5% P=0.90) and abortion rate(11.9%; 12.8% P=0.90).

Limitations, reasons for caution

In our study, we were not able to select only unexplained RM patients. We believed ICSI can be helpful, although not complete, just like the pre-implantation genetic diagnosis (PGD) method. However ICSI was not able to decrease abortion rate.

Wider implications of the findings

ICSI fertilization method was carried out on women with recurrent miscarriage in order to reducing paternal chromosomal abnormality. However, the results showed that there was no positive effect in both pregnancy rate and abortion rate. It seems that the ICSI would not be necessary for such patients. Our study shows chromosomally abnormal sperm cannot be detected by ICSI alone and various causes can lead to unexplained recurrent miscarriage.

  • 2016년 유럽불임학회(ESHRE) P-062 인공수정시술을 하기 전 얼마나 오래 금욕을 해야 하는가?
  • 2015년 미국불임학회(ASRM) P-344 과배란 인공수정에서 매일 황체기 보강을 하는 것이 임신율 향상에 도움을 준다.
  • 2015년 미국불임학회(ASRM) P-267 자연주기에서 단순화한 검사에 의한 동결란 이식은 체외수정시술결과에 영향을 주지 않는다.
  • 2015년 유럽불임학회(ESHRE) P-769 일측 난관수종이 있는 경우, 거의 절반의 경우 반대쪽 난관에 이상이 있어 추가적인 수술이 필요하다.
  • 2014년 미국불임학회(ASRM) P-822 경미한 희소정자증을 보일 때 미세수정을 통한 시험관 시술이 반드시 필요한가?
  • 2014년 유럽불임학회(ESHRE) P-045 반복 유산 여성에서 미세수정을 통한 시험관 시술은 자연 유산을 감소시키지 않는다.
  • 2014년 유럽불임학회(ESHRE) P-506 과배란시험관 시술 시에 hCG 주사일에 FSH 투여하는 것이 미치는 영향
  • 2013년 유럽불임학회(ESHRE) P-495 시험관 시술에서 황체기 보강을 위해 질내 프로게스테론 젤에 추가로 저용량의 hCG를 투여하는 것의 효과